Clinical Trial Update: DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

View source ↗

Summary

This clinical trial registry entry describes the DeciPHer-ILD real-world patient registry focused on Group 3 pulmonary hypertension associated with interstitial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Pulmonary Hypertension
• Pulmonary Hypertension Due to Lung Diseases and Hypoxia

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension | Status: RECRUITING